Abstract:Toxoplasma gondii is an obligate intracellular parasite that infects one-third of the world's human population and establishes infection in the brain. Cerebral immune cell infiltration is critical for controlling the parasite, but little is known about the molecular cues guiding immune cells to the brain during infection. Activated astrocytes produce CCL2, a chemokine that mediates inflammatory monocyte recruitment to tissues by binding to the CCR2 receptor. We detected elevated CCL2 production in the brains of C57BL/6J mice by 15 days after T . gondii infection. Utilizing confocal microscopy and intracellular flow cytometry, we identified microglia and brain-infiltrating myeloid cells as the main producers of CCL2 during acute infection, and CCL2 was specifically produced in regions of parasite infection in the brain. In contrast, astrocytes became the dominant CCL2 producer during chronic T . gondii infection. To determine the role of astrocyte-derived CCL2 in mobilizing immune cells to the brain and controlling T . gondii infection, we generated GFAP-Cre x CCL2 fl/fl mice, in which astrocytes are deficient in CCL2 production. We observed significantly decreased immune cell recruitment and increased parasite burden in the brain during chronic, but not acute, infection of mice deficient in astrocyte CCL2 production, without an effect on peripheral immune responses. To investigate potential mechanisms explaining the reduced control of T . gondii infection, we analyzed key antimicrobial and immune players in host defense against T . gondii and detected a reduction in iNOS + myeloid cells, and T . gondii -specific CD4 + T cells in the knockout mice. These data uncover a critical role for astrocyte-derived CCL2 in immune cell recruitment and parasite control in the brain during chronic, but not acute, T . gondii infection. Neuroinflammation plays an important role in protecting the brain against infection, but it must be controlled to prevent damage to the brain. Toxoplasma gondii is an obligate intracellular foodborne parasite that infects one-third of the world's human population. Among pathogens, T . gondii has the rare ability to cross the blood-brain barrier and establish chronic infection in the brain, inducing a protective, but non-sterilizing immune response. In this study, we examined T . gondii infection of mice to understand the factors driving the neuroinflammatory response to infection of the brain. We determined that the cells producing the potent chemokine, CCL2, changed over the course of infection: myeloid cells were the main CCL2 producers during acute infection, whereas astrocytes became the dominant CCL2 producers during chronic infection. Additionally, the ablation of CCL2 production specifically from astrocytes reduced immune cell recruitment to the brain and decreased control of the parasite during chronic infection. Therefore, astrocyte-derived CCL2 plays a critical role in the control of chronic, but not acute, T . gondii infection.

Toxoplasma infection induces an aged neutrophil population in the CNS that is associated with neuronal protection

Deficiency in astrocyte CCL2 production reduces neuroimmune control of Toxoplasma gondii infection

Toxoplasma gondii infection and its implications within the central nervous system

From Inflammatory Reactions to Neurotransmitter Changes: Implications for Understanding the Neurobehavioral Changes in Mice Chronically Infected with Toxoplasma Gondii.

Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain

Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles altering astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain

Group 1 metabotropic glutamate receptor expression defines a T cell memory population during chronic Toxoplasma infection that enhances IFN-gamma and perforin production in the CNS

Protective function and differentiation cues of brain-resident CD8+ T cells during surveillance of latent Toxoplasma gondii infection

Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by Toxoplasma gondii infection

Behavior and neuropsychiatric changes in experimental chronic toxoplasmosis: Histopathological and immunohistochemical studies

Toxoplasmosis of the central nervous system: Manifestations vary with immune responses

4D label-free proteomic analysis reveals key potential pathways of Toxoplasma invasion into the central nervous system

Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii

Toxoplasma gondii infection accelerates the progression of hereditary spastic paraplegia

Toxoplasma gondii Infection of BALB/c Mice Perturbs Host Neurochemistry

T lymphocyte-dependent IL-10 down-regulates a cytokine storm driven by Toxoplasma gondii GRA24

A metabolite attenuates neuroinflammation, synaptic loss and cognitive deficits induced by chronic infection of Toxoplasma gondii

Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts

Divergent CD8 memory T cell subsets in an encephalitis model of Toxoplasma gondii infection

Host autophagy is exploited by the intracellular parasite Toxoplasma gondii to enhance amino acids levels

Activation of Chronic Toxoplasmosis by Transportation Stress in a Mouse Model